TFRC and hepatocellular carcinoma: Nanovesicles engineered for surface Tf-Fe3+ display and SOR encapsulation (SOR@TF-Fe3+ NVs) achieved TfR-directed HCC targeting, enhancing tumoral iron/SOR accumulation and ferroptosis induction while maintaining favorable liver distribution [177].